About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Colorectal CancerSeattle

Colorectal Cancer Clinical Trials in Seattle

Find 214 clinical trials for colorectal cancer near Seattle, Washington. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 214 trials

CompletedFR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00077337·Mobile, Alabama and 87 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSystems of Support (SOS) to Increase Colon Cancer Screening and Follow-up SupplementAncillary Aim #1 We will evaluate intervention effects by comparing binary outcomes for screening (yes/no) in the primary SOS study.NCT01052922·Seattle, Washington

TerminatedA Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerThis 2-arm study was designed to evaluate the efficacy and safety of 2 treatment regimens of Xeloda and Avastin, with either irinotecan or oxaliplatin administered for the first…NCT00642603·PARK Springs, Arizona and 75 others

TerminatedA Study to Investigate LYL845 in Adults With Solid TumorsThis is an open-label, multi-center, dose-escalation study with expansion cohorts, designed to evaluate the safety and anti-tumor activity of LYL845, an epigenetically…NCT05573035·Sacramento, California and 17 others

RecruitingA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C.NCT06997497·Phoenix, Arizona and 244 others

CompletedA Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatThe purpose of this study was to combine the PDR001 checkpoint inhibitor with several agents with immunomodulatory activity to identify the doses and schedule for combination…NCT02890069·Santa Monica, California and 24 others

CompletedSurgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00023751·Anniston, Alabama and 179 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 750 others

RecruitingCollecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsThis study collects blood and stool samples from patients with suspected or diagnosed Lynch syndrome to evaluate a deoxyribonucleic acid (DNA) screening technique for the…NCT05410977·Scottsdale, Arizona and 8 others

CompletedSurgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverRATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells.NCT00030563·Cleveland, Ohio and 2 others

Active not recruitingS0820, Adenoma and Second Primary Prevention TrialThe investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal…NCT01349881·Birmingham, Alabama and 988 others

RecruitingStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with…NCT06445062·Chandler, Arizona and 31 others

RecruitingA Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT TrialThis clinical trial studies whether an intervention that addresses two or more levels of care (multilevel intervention) increases follow-up of abnormal, non-invasive, colorectal…NCT06822530·Seattle, Washington

CompletedStudy of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerThe study will determine the maximum tolerated dose (MTD) of AUY922 given in combination with cetuximab in previously treated patients with KRAS wild-type metastatic colorectal…NCT01294826·Seattle, Washington

RecruitingImproving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web EducationThis pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation…NCT06995924·Seattle, Washington and 1 other

RecruitingA Study of IBI363 in Subjects with Advanced Solid MalignanciesThis is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in subjects with advanced, refractory solid…NCT06281678·San Francisco, California and 8 others

CompletedS1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerThis randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal cancer that has…NCT02164916·Anchorage, Alaska and 762 others

CompletedStudy of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerThis study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancerNCT04208958·Scottsdale, Arizona and 17 others

TerminatedRP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRCThis is an open-label, Phase 2 clinical trial evaluating therapy with an oncolytic immunotherapy (RP2 or RP3) in combination with atezolizumab and bevacizumab in patients with…NCT05733611·Los Angeles, California and 1 other

TerminatedA First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursA Phase I/IIa First-in-human, Open-label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD8853 in Participants with Selected…NCT05397171·Atlanta, Georgia and 5 others

PreviousPage 9 of 11Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma